Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

2826 with DOI

0 strong · 22 moderate · 6 weak

Compilations

12026-05-09T15:30:45.588Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

34last ruled 2026-06-04

1 awaiting a ruling

Issued documents

42026-10-19T20:32:01.634Z

notice · info card · emergency

Searches

151 with no results

queries and counts on the build

Claims checked

7962 supported

62 supported · 17 not

Correspondence

0received

consent field ships in Phase 4

Edges

247

derivations recorded for this entity

Complete over 28 sources, 1 compilation, and 34 decisions.Not here: the private journal (never); 1 proposal awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/flubromazepam/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued info_card
  2. 2026-10-02srcDetectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays
  3. 2026-10-02srcFlubromazolam - Basic pharmacokinetic evaluation of a highly potent designer benzodiazepine
  4. 2026-10-02srcChanging trends in novel benzodiazepine use within Scottish prisons: detection, quantitation, prevalence, and modes of use
  5. 2026-10-02srcDetection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics
  6. 2026-10-02srcThe Evolution of Benzodiazepine Allosteric Modulators: Structural Insights From Historical Milestones to Emerging Innovations
  7. 2026-10-02srcDesigner benzodiazepines: A new challenge
  8. 2026-10-02srcIntoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities
  9. 2026-10-02srcAssessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances-Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam-in the UK
  10. 2026-10-02srcUrine analysis of 28 designer benzodiazepines by liquid chromatography-high-resolution mass spectrometry
  11. 2026-10-02srcAn outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program
  12. 2026-10-02srcBlood concentrations of new designer benzodiazepines in forensic cases.
  13. 2026-10-02srcRetrospective screening of synthetic cannabinoids, synthetic opioids and designer benzodiazepines in data files from forensic post mortem samples analysed by UHPLC-QTOF-MS from 2014 to 2018
  14. 2026-10-02srcCompletion of the Set: Synthesis of the (6,X')-Flubromazepam Positional Isomers as Standards for Forensic Analysis
  15. 2026-10-02srcSynthesis of Flubromazepam Positional Isomers for Forensic Analysis
  16. 2026-10-02srcAnalytically diagnosed intoxication by 2-methoxphenidine and flubromazepam mimicking an ischemic cerebral disease
  17. 2026-10-02srcOccurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project.
  18. 2026-10-02srcDesigner benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014-2017.
  19. 2026-10-02srcThe Evolution Toward Designer Benzodiazepines in Drug-Facilitated Sexual Assault Cases
  20. 2026-10-02srcFast and Sensitive Method for the Determination of 17 Designer Benzodiazepines in Hair by Liquid Chromatography-Tandem Mass Spectrometry
  21. 2026-10-02srcELISA Detection of Phenazepam, Etizolam, Pyrazolam, Flubromazepam, Diclazepam and Delorazepam in Blood Using Immunalysis Benzodiazepine Kit
  22. 2026-10-02srcA Case Study Involving U-47700, Diclazepam and Flubromazepam-Application of Retrospective Analysis of HRMS Data
  23. 2026-10-02srcSuccessful symptom-based management of active withdrawal from multiple illicit benzodiazepines
  24. 2026-10-02srcRecent findings and advancements in the detection of designer benzodiazepines: a brief review
  25. 2026-10-02srcNovel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects
  26. 2026-10-02srcDesigner Benzodiazepines: A Review of Toxicology and Public Health Risks
  27. 2026-10-02srcBenzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques
  28. 2026-10-02srcWHO ECDD 46th Meeting: Critical Review of Flubromazepam
  29. 2026-10-02srcDEA: Five Synthetic Benzodiazepine Drugs Deemed Imminent Hazard to Public Safety
  30. 2026-09-04issueIssued emergency
  31. 2026-09-04issueIssued info_card
  32. 2026-09-04issueIssued notice
  33. 2026-07-03proposaldependence · taper
  34. 2026-06-04proposal31 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  35. 2026-06-04publicationPublication — backfill
  36. 2026-05-09revisionRevision 1
  37. 2026-05-09absenceSearched ClinicalTrials.gov for "flubromazepam" — no results
  38. 2026-05-09genGeneration — pipeline-v5 · with 3 morepipeline-v5
  39. 2026-05-09rungeneration run

The same entries, as forms: six forms.